Each 1 mL of Liposomal Glutathione delivers 100 mg of Opitac Reduced Glutathione
Here's how they compare: Semaglutide (GLP-1 agonist) Mechanism: Single-action GLP-1 receptor agonist FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: 15-20% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients starting their weight loss journey seeking proven, well-studied medication Tirzepatide (dual GIP/GLP-1 agonist) Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic effect FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: Up to 22% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients seeking more aggressive fat loss with dual-action metabolic support Retatrutide (triple agonist, not yet available) Mechanism: Targets GLP-1, GIP, and glucagon receptors FDA status: Not FDA-approved

Consider both if As discussed in the combination section, running cagrilintide alongside retatrutide represents the theoretical maximum in multi-receptor weight loss pharmacology
For best results, pair GLP-1 gummies with balanced meals, protein-focused snacks, regular movement, and healthy daily habits
Although its cost is relatively high, its anti-aging and repairing effects have been verified by medical clinical trials
Branched-chain amino acids have been proven to increase muscle growth, prevent muscle wasting, and reduce exercise fatigue